Abstract
The aim of this study was to prepare efficient imprinted polymer nanoparticles from an olanzapine template for the controlled release of olanzapine as a therapeutic drug for CNS diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have